Virchow的档案 SCIE

期刊简介预计审稿时间： 偏慢,4-8周

Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.

欢迎使用免疫细胞化学、分子和超微结构技术来强化现代诊断病理学证据基础的原创研究手稿。此外，还将考虑关于诊断标准的批判性评估以及具有坚实证据基础的宣传单和指南的论文。还将考虑与理解人类病理学相关的其他领域的工作报告以及关于在病理学中应用新方法和技术的手稿。不鼓励提交纯实验性文章，但欢迎提交适用于诊断病理学的实验性工作手稿。欢迎生物标志物研究，但需要遵守足够的样本量和相关标志物选择的严格规则（例如 REMARK）。没有经过验证的应用的有限患者系列的单一标志物研究通常不予考虑。只有当病例报告提供大量新信息并对理解疾病或诊断实践产生影响时，才会考虑它们。

《Virchows Archiv》(Virchow的档案)编辑部通讯方式为SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。